MaxLinear Reports Q4 Results, Joins ING, Wolfspeed And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

2/1/24 5:10:08 AM ET

$AFL

$ARQT

$ING

$MXL

Accident &Health Insurance

Finance

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $AFL alert in real time by email

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 90 points on Thursday.

Shares of MaxLinear, Inc. (NYSE:MXL) shares fell sharply during Thursday’s pre-market trading after reporting fourth-quarter results.

MaxLinear posted adjusted earnings of 1 cent per share, compared to market estimates of 1 cent per share. The company’s quarterly sales came in at $125.35 million versus expectations of $125.11 million, according to data from Benzinga Pro.

MaxLinear shares dipped 13.4% to $18.00 in pre-market trading.

Here are some big stocks recording losses in today’s pre-market trading session.

ING Groep N.V. (NYSE:ING) shares declined 8.7% to $12.97 in pre-market trading following fourth-quarter results.
Nyxoah S.A. (NASDAQ:NYXH) shares tumbled 8.4% to $9.91 in pre-market trading after jumping around 33% on Wednesday.
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) shares fell 8% to $5.40 in pre-market trading. Steven Cohen reported a 5.2% passive stake in Arcutis Biotherapeutics in 13G Filing.
Rocket Lab USA, Inc. (NASDAQ:RKLB) shares declined 6.8% to $4.52 in pre-market trading after the company announced a proposed offering of $275 million convertible senior notes.
Wolfspeed, Inc. (NYSE:WOLF) shares fell 6.5% to $30.45 in pre-market trading following the company's second-quarter earnings.
ZoomInfo Technologies Inc. (NASDAQ:ZI) fell 3.1% to $15.55 in pre-market trading. B of A Securities recently upgraded the stock from Neutral to Buy and raised its price target from $20 to $25.
Aflac Incorporated (NYSE:AFL) shares declined 2.1% to $82.55 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results.
Sanofi (NASDAQ:SNY) fell 2% to $48.88 in pre-market trading after the company posted fourth-quarter results and named François-Xavier Roger as Chief Financial Officer.

Now Read This: Apple, Honeywell International And 3 Stocks To Watch Heading Into Thursday

Don’t forget to check out our premarket coverage here

Get the next $AFL alert in real time by email

Recent Analyst Ratings for

Company	Date	Price Target	Rating	Analyst
Sanofi $SNY	2/12/2026		Buy → Neutral	BofA Securities
ING Group N.V. $ING	2/2/2026		Hold → Buy	Deutsche Bank
Sanofi $SNY	1/27/2026		Neutral	Citigroup
ING Group N.V. $ING	1/27/2026		Hold	Jefferies
Sanofi $SNY	1/16/2026		Buy → Neutral	UBS
Rocket Lab Corporation $RKLB	1/16/2026	$105.00	Equal-Weight → Overweight	Morgan Stanley
Rocket Lab Corporation $RKLB	1/15/2026		Overweight → Sector Weight	KeyBanc Capital Markets
Sanofi $SNY	1/6/2026		Overweight → Equal Weight	Barclays

More analyst ratings

MaxLinear Reports Q4 Results, Joins ING, Wolfspeed And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

2/1/24 5:10:08 AM ET

Accident &Health Insurance

Finance

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $AFL alert in real time by email

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 90 points on Thursday.

Shares of MaxLinear, Inc. (NYSE:MXL) shares fell sharply during Thursday’s pre-market trading after reporting fourth-quarter results.

MaxLinear shares dipped 13.4% to $18.00 in pre-market trading.

Here are some big stocks recording losses in today’s pre-market trading session.

ING Groep N.V. (NYSE:ING) shares declined 8.7% to $12.97 in pre-market trading following fourth-quarter results.
Nyxoah S.A. (NASDAQ:NYXH) shares tumbled 8.4% to $9.91 in pre-market trading after jumping around 33% on Wednesday.
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) shares fell 8% to $5.40 in pre-market trading. Steven Cohen reported a 5.2% passive stake in Arcutis Biotherapeutics in 13G Filing.
Rocket Lab USA, Inc. (NASDAQ:RKLB) shares declined 6.8% to $4.52 in pre-market trading after the company announced a proposed offering of $275 million convertible senior notes.
Wolfspeed, Inc. (NYSE:WOLF) shares fell 6.5% to $30.45 in pre-market trading following the company's second-quarter earnings.
ZoomInfo Technologies Inc. (NASDAQ:ZI) fell 3.1% to $15.55 in pre-market trading. B of A Securities recently upgraded the stock from Neutral to Buy and raised its price target from $20 to $25.
Aflac Incorporated (NYSE:AFL) shares declined 2.1% to $82.55 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results.
Sanofi (NASDAQ:SNY) fell 2% to $48.88 in pre-market trading after the company posted fourth-quarter results and named François-Xavier Roger as Chief Financial Officer.

Now Read This: Apple, Honeywell International And 3 Stocks To Watch Heading Into Thursday

Don’t forget to check out our premarket coverage here

Get the next $AFL alert in real time by email

Recent Analyst Ratings for

Company	Date	Price Target	Rating	Analyst
Sanofi $SNY	2/12/2026		Buy → Neutral	BofA Securities
ING Group N.V. $ING	2/2/2026		Hold → Buy	Deutsche Bank
Sanofi $SNY	1/27/2026		Neutral	Citigroup
ING Group N.V. $ING	1/27/2026		Hold	Jefferies
Sanofi $SNY	1/16/2026		Buy → Neutral	UBS
Rocket Lab Corporation $RKLB	1/16/2026	$105.00	Equal-Weight → Overweight	Morgan Stanley
Rocket Lab Corporation $RKLB	1/15/2026		Overweight → Sector Weight	KeyBanc Capital Markets
Sanofi $SNY	1/6/2026		Overweight → Equal Weight	Barclays

More analyst ratings

MaxLinear Reports Q4 Results, Joins ING, Wolfspeed And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $AFL$ARQT$ING$MXL

MaxLinear Reports Q4 Results, Joins ING, Wolfspeed And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $AFL$ARQT$ING$MXL

$AFL$ARQT$ING$MXL Press Releases

MaxLinear Announces New Employee Inducement Grants

Pentagon Pours $68M Into Hypersonic Tech: Here Are Five Firms Building the Hardware

Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East

$AFL$ARQT$ING$MXL SEC Filings

SEC Form 144 filed by AFLAC Incorporated

Amendment: SEC Form SCHEDULE 13G/A filed by Wolfspeed Inc.

Amendment: SEC Form SCHEDULE 13D/A filed by Rocket Lab Corporation

$AFL$ARQT$ING$MXL Insider Purchases

Large owner Citigroup Inc bought $5,160,602 worth of shares (194,305 units at $26.56) and sold $5,089,994 worth of shares (194,423 units at $26.18) (SEC Form 4)

Director Heron Patrick J bought $34,610 worth of shares (2,646 units at $13.08) (SEC Form 4)

Director Heron Patrick J bought $30,247 worth of shares (2,268 units at $13.34) (SEC Form 4)

$AFL$ARQT$ING$MXL Analyst Ratings

Sanofi downgraded by BofA Securities

ING Groep upgraded by Deutsche Bank

Citigroup initiated coverage on Sanofi

$AFL$ARQT$ING$MXL FDA approvals

March 28, 2025 - FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors

February 14, 2025 - FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes

FDA Approval for SOLIQUA 100/33 issued to SANOFI-AVENTIS US

$AFL$ARQT$ING$MXL Insider Trading

Sr. Executive Vice President Tillman Audrey B gifted 304 shares, decreasing direct ownership by 0.12% to 257,619 units (SEC Form 4)

SEC Form 4 filed by Director Sennesael Kris

SEC Form 3 filed by new insider Sennesael Kris

$AFL$ARQT$ING$MXL Leadership Updates

Sanofi announces leadership evolution in Specialty Care Business Unit

Wolfspeed Strengthens Global Sales Leadership with Addition of Semiconductor Leader, Stefan Steyerl, as VP of Sales, EMEA

Wolfspeed Announces CFIUS Clearance and Completion of Equity Issuance to Renesas as Part of Court-Approved Restructuring

$AFL$ARQT$ING$MXL Financials

Aflac Incorporated Announces Fourth Quarter Results, Reports Fourth Quarter Net Earnings of $1.4 Billion, Reiterates Increase in First Quarter Dividend of 5.2%

Wolfspeed Reports Financial Results for the Second Quarter of Fiscal 2026

Wolfspeed, Inc. Announces Date of Fiscal Second Quarter Earnings Call for February 4, 2026

$AFL$ARQT$ING$MXL Large Ownership Changes

Amendment: SEC Form SC 13G/A filed by Wolfspeed Inc.

Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

Amendment: SEC Form SC 13G/A filed by Wolfspeed Inc.

Recent Analyst Ratings for
$AFL
$ARQT
$ING
$MXL

Recent Analyst Ratings for
$AFL
$ARQT
$ING
$MXL

$AFL
$ARQT
$ING
$MXL
Press Releases

$AFL
$ARQT
$ING
$MXL
SEC Filings

$AFL
$ARQT
$ING
$MXL
Insider Purchases

$AFL
$ARQT
$ING
$MXL
Analyst Ratings

$AFL
$ARQT
$ING
$MXL
FDA approvals

$AFL
$ARQT
$ING
$MXL
Insider Trading

$AFL
$ARQT
$ING
$MXL
Leadership Updates

$AFL
$ARQT
$ING
$MXL
Financials

$AFL
$ARQT
$ING
$MXL
Large Ownership Changes